INS and myeloid sarcoma: Higher mean CAPs were observed in patients using insulin compared to those who did not (237.4 ± 60.4 vs. 209.6 ± 50.0, p = 0.04, respectively) and in those with MS compared to those without (233.2 ± 51.8 vs. 209.6 ± 50.0, p = 0.004, respectively).